API | sulodexide

sulodexide Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Sulodexide, traded as Aterina, is a highly purified mixture of glycosaminoglycans composed of low molecular weight heparin (80%) and dermatan sulfate (20%). ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
sulodexide

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Organizations (22)

Research & Development (22)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (17)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (17)

Aged (Phase 3)

Albuminuria (Phase 4)

Anticoagulants (Phase 3)

COVID-19 (Phase 2/Phase 3)

Diabetes Mellitus (Phase 4)

Diabetic Nephropathies (Phase 4)

Diabetic Retinopathy (Phase 2)

Drug Therapy (Phase 3)

Glomerulonephritis, Membranoproliferative (Phase 1)

Minimally Invasive Surgical Procedures (Phase 3)

Peripheral Arterial Disease (Phase 3)

Postthrombotic Syndrome (Phase 4)

Prostatic Diseases (Phase 3)

Prostatic Hyperplasia (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Tinnitus (Phase 2)

Venous Thromboembolism (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 16
# of Trial Organizations: 22

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue